NFKBIE
NFKBIE (NFKB inhibitor epsilon, also known as IKBE) is a cytoplasmic member of the NF-kappa-B inhibitor family. It sequesters NF-kappa-B transcription factor complexes in the cytoplasm, limiting their activity and helping to restrain B-cell activation. Browse Assay Genie's current range of NFKBIE research reagents below, or read on for the biology behind the target.
NFKBIE acts as a brake on NF-kappa-B signalling. The protein binds components of NF-kappa-B and traps the complex in the cytoplasm, preventing it from activating genes in the nucleus. The complexes it sequesters include NFKB1-RELA (p50-p65) and NFKB1-REL (p50-c-Rel). Through this activity, NFKBIE limits B-cell activation in response to pathogens and also plays an important role in B-cell development.
Release from inhibition is controlled by post-translational modification. Phosphorylation of the NFKBIE protein targets it for destruction by the ubiquitin pathway. Once it is degraded, NF-kappa-B is free to translocate to the nucleus, where it can activate gene expression. This makes NFKBIE a useful point of study for researchers examining how the timing and strength of NF-kappa-B activity are set.
The NFKBIE gene belongs to the HGNC groups for ankyrin repeat domain containing proteins and the NFKB inhibitor family. It was previously named nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon, and the alias IKBE is still in use. The mouse ortholog is Nfkbie. Researchers studying NFKBIE often work with it alongside other NF-kappa-B pathway components, using an NFKBIE antibody or NFKBIE ELISA kit to follow protein levels.
NFKBIE holds NF-kappa-B complexes in the cytoplasm, making it a regulator to examine when studying how NF-kappa-B activity is restrained and released.
NFKBIE limits B-cell activation in response to pathogens and contributes to B-cell development, linking it to studies of B-cell regulation.
Phosphorylation targets NFKBIE for destruction by the ubiquitin pathway, providing a model for how inhibitor turnover activates NF-kappa-B.
By restricting NF-kappa-B activation of nuclear genes, NFKBIE is relevant to research on how cells control responses to pathogens.
NFKBIE sequesters NF-kappa-B transcription factor complexes, including NFKB1-RELA (p50-p65) and NFKB1-REL (p50-c-Rel), in the cytoplasm and inhibits their activity. In doing so it limits B-cell activation in response to pathogens and contributes to B-cell development.
The official name is NFKB inhibitor epsilon, and the symbol NFKBIE is used for the gene. IKBE is a recognised alias. The earlier HGNC name was nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon. UniProt lists it as NF-kappa-B inhibitor epsilon.
Phosphorylation of NFKBIE targets it for destruction by the ubiquitin pathway, which frees NF-kappa-B to move into the nucleus. A mouse ortholog, Nfkbie, exists; check the datasheet of any product for its validated reactivity.
Other NF-κB inhibitors, NF-κB subunits and pathway components studied alongside NFKBIE.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O00221; product specifications from Assay Genie datasheets.